Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

MREOMREO
11 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in MEREO BIOPHARMA GROUP PLC

ADAGE CAPITAL PARTNERS GP, L.L.C. previously held 0 shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$2.4M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$2.66
0
2025-Q1
Decreased
1.7M
-80.5%
$3.8M0.0%$2.30
0
2024-Q4
Decreased
8.7M
-10.3%
$30.5M0.1%$3.52
0
2024-Q3
Decreased
9.7M
-17.6%
$39.9M0.1%$4.14
0
2024-Q2
Increased
11.8M
+26.4%
$42.4M0.1%$3.60
36
2024-Q1
Increased
9.3M
+252.0%
$30.8M0.1%$3.30
47
2023-Q4
Increased
2.7M
+231.3%
$6.1M0.0%$2.31
44
2023-Q3
New
800,000
-
$1M0.0%$1.29
35
2022-Q1
Exited
0
-100.0%
$00.0%$1.04
0
2021-Q4
Unchanged
1M
0.0%
$1.6M0.0%$1.61
0
2021-Q3
New
1M
-
$2.4M0.0%$2.40
36

Other major holders of MREO: Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used